Edwards Lifesciences Other countries — Tax Benefit Amount increased by 17.0% to $104.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.0%, from $89.30M to $104.50M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates improved tax efficiency or higher utilization of regional tax incentives.
The specific tax benefit recognized in the financial statements derived from operations in international regions outside...
Commonly reported as part of the geographic tax rate reconciliation in annual reports.
ew_segment_other_countries_tax_benefit_amount| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $60.10M | $65.50M | $71.60M | $89.30M | $104.50M |
| QoQ Change | — | +9.0% | +9.3% | +24.7% | +17.0% |
| YoY Change | — | +9.0% | +9.3% | +24.7% | +17.0% |